The Patent Finder

Terms ending in 2033

Rhodes Technologies

Every in-force patent on Rhodes Technologies's record whose computed term ends in 2033, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 10,202,396Process for Improved Opioid Synthesis
In force
 · High confidence
Knoa Pharma LLCIn forceHigh confidence
US 11,390,627Process for Improved Opioid Synthesis
In force
 · High confidence
Knoa Pharma LLCIn forceHigh confidence
US 9,315,5141,3-Dioxanomorphides and 1,3-Dioxanocodides
In force
 · High confidence
Noramco, LLCIn forceHigh confidence
US 10,316,042Process for Improved Opioid Synthesis
In force
 · High confidence
Knoa Pharma LLCIn forceHigh confidence
US 9,834,5627 beta-Substituted 6a,14a-Ethenomorphinans and 7beta-Substituted 6a,14a-Ethanomorphinans
In force
 · High confidence
Knoa Pharma LLCIn forceHigh confidence
US 10,624,859Systems and Methods for Increasing Stability of Dronabinol Compositions
In force
 · High confidence
Rhodes TechnologiesIn forceHigh confidence
6 of 6 patents shown. Soonest term end first, then patent number.
1 of these is in force and held by Rhodes Technologies.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited